Data / Drug companies / Aspirin, chlorpheniramine maleate, phenylephrine bitartrate
Aspirin, chlorpheniramine maleate, phenylephrine bitartrate: 16 companies and 24 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Aspirin, chlorpheniramine maleate, phenylephrine bitartrate is listed in the FDA National Drug Code Directory by 16 companies, with 24 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, effervescent, and the newest product started marketing on June 5, 2026.
The request: Get every company that lists aspirin, chlorpheniramine maleate, phenylephrine bitartrate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 16
- Products
- 24
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Effervescent Orange Cold Relief, Quality Choice Effervescent Cold Relief - Orange, Meijer Effervescent Cold Relief, Top Value Effervescent Cold Relief - Orange, Alka-Seltzer Plus Cold Orange Zest, Equaline Effervescent Cold Relief, Best Choice Effervescent Cold Relief, Walgreens Effervescent Cold Relief Plus
- openFDA record search
- api.fda.gov
Companies that list aspirin, chlorpheniramine maleate, phenylephrine bitartrate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bayer HealthCare LLC. | 6 | tablet, effervescent | Over the counter monograph drugs | June 1, 2026 |
| Chain Drug Marketing Association, Inc. | 2 | tablet, effervescent | Over the counter monograph drugs | June 5, 2026 |
| Meijer Distribution Inc | 2 | tablet, effervescent | Over the counter monograph drugs | June 6, 2024 |
| Tower Laboratories Ltd | 2 | tablet, effervescent | Over the counter monograph drugs | April 16, 2021 |
| CVS Pharmacy | 1 | tablet, effervescent | Over the counter monograph drugs | March 10, 2017 |
| Chain Drug Marketing Association | 1 | tablet, effervescent | Over the counter monograph drugs | June 15, 2020 |
| Discount Drug Mart | 1 | tablet, effervescent | Over the counter monograph drugs | January 30, 2015 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | tablet, effervescent | Over the counter monograph drugs | September 15, 2015 |
| Family Dollar (family Wellness) | 1 | tablet, effervescent | Over the counter monograph drugs | October 19, 2023 |
| H E B | 1 | tablet, effervescent | Over the counter monograph drugs | January 30, 2018 |
| Kroger Company | 1 | tablet, effervescent | Over the counter monograph drugs | April 21, 2014 |
| Perrigo Direct, Inc | 1 | tablet, effervescent | Over the counter monograph drugs | November 15, 2021 |
| United Natural Foods, Inc. DBA Unfi | 1 | tablet, effervescent | Over the counter monograph drugs | May 29, 2014 |
| Valu Merchandisers Company | 1 | tablet, effervescent | Over the counter monograph drugs | December 10, 2013 |
| Wal-Mart Stores Inc | 1 | tablet, effervescent | Over the counter monograph drugs | November 2, 2017 |
| Walgreen Company | 1 | tablet, effervescent | Over the counter monograph drugs | October 24, 2014 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, effervescent | 24 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 24 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Histamine-1 Receptor Antagonist | 24 |
| Nonsteroidal Anti-inflammatory Drug | 24 |
| Platelet Aggregation Inhibitor | 24 |
| alpha-1 Adrenergic Agonist | 24 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.